Latest news with #stemcellresearch
Zawya
11-06-2025
- Health
- Zawya
Hong Kong Hosts World's Largest ISSCR Stem Cell Gathering for the First Time
Some 2,400 stem cell and regenerative medicine pioneers convene to chart new frontiers, resulting from bidding efforts of Hong Kong Convention Ambassadors of the Hong Kong Tourism Board HONG KONG SAR - Media OutReach Newswire - 11 June 2025 - Reputed to be a leading research and development (R&D) hub for medical sciences, Hong Kong hosts the world's largest and most significant gathering of stem cell research and regenerative medicine, the International Society of Stem Cell Research (ISSCR) 2025 Annual Meeting. The event is brought to Hong Kong for the first time, thanks to the joint effort of three local universities – The University of Hong Kong, The Chinese University of Hong Kong and the Hong Kong University of Science and Technology, which are appointed organisations under the Hong Kong Convention Ambassador (HKCA) programme of the Hong Kong Tourism Board (HKTB). The four-day meeting held on June 11-14 gathers more than 2,400 local and international experts in stem cell research and regenerative medicine from 58 countries and regions, from Asia to North America, Europe, Australia, the Middle East, and Mainland China. Pioneers share the latest advances in the field, with topics spanning the field of regenerative medicine including topics such as advances in cell therapies, fundamental discoveries, understanding disease processes and more. Dr Peter Lam, HKTB Chairman, said, "The International Society for Stem Cell Research (ISSCR) is a globally leading organisation in medical sciences and research, and its annual meeting is one of the world's most significant international academic conventions in medical science. Hong Kong is the first city chosen to host this annual event in Asia after a 13-year hiatus, underscoring the city's status as the 'World's Meeting Place'. I am grateful for the active participation of the Hong Kong Convention Ambassadors from the three local universities, who leveraged their influence and network during the bidding for the host of the event to make the event come true. We are also delighted to see that more professionals from a wider range of expertise are joining HKTB's league of Convention Ambassadors, and we believe their participation can help identify and contribute to the staging of more significant international events in Hong Kong." Valentina Greco, ISSCR President, remarked, "Hosting ISSCR 2025 in Hong Kong marks a defining moment for global stem cell science. As a vibrant research hub at the crossroads of Asia and the world, Hong Kong offers an ideal setting to connect diverse scientific communities, spark new collaborations, and accelerate innovation. The ISSCR is deeply grateful to the city of Hong Kong and to our generous co-sponsors – the University of Hong Kong, The Chinese University of Hong Kong, and the Hong Kong University of Science and Technology – for their support and commitment to bringing The Global Stem Cell Event to this beautiful city. With the unwavering support of the Hong Kong Tourism Board, these three leading universities, and inspired leadership from our 2025 Annual Meeting Program Committee, this meeting exemplifies the power of partnership and shared vision. We are proud to return to Asia for the first time in more than a decade at a time when our collective progress in stem cell research and regenerative medicine and to advancing therapies that have life altering impact on patients depends on the exchange of bold ideas across borders." The extensive programme features plenary sessions, concurrent tracks, poster presentations, and networking opportunities. Contributing to the success of the event, the HKTB has provided comprehensive support, from arranging reconnaissance to venue sourcing, bid proposal, network support and more. Hong Kong Convention Ambassador Programme Aligns a Record Lineup of 180 Industry Leaders HKCAs have been instrumental in winning the ISSCR 2025 Annual Meeting for Hong Kong. Launched in 2020 by the HKTB as a strategic initiative, the HKCA programme recruits high-level representatives of Hong Kong's eight universities, chambers of commerce, professional organisations, public bodies, industrial entities and professional societies to act as ambassadors for Hong Kong's convention sector. With their professional influence and networks, HKCAs have led efforts to bring in events ranging from medical sciences to innovation and technology (I&T), financial services, aviation, transportation and more. The close collaboration between HKCAs and the HKTB has proven effective in promoting Hong Kong as a premier hub for world-class conventions. As an alliance of distinguished local and Mainland leaders in business, medicine, professional services, I&T and other fields, the HKCA programme has been growing from strength to strength, with 72 new members in the latest record-sized cohort for the 2025-2026 term, taking the total to about 180, some 30% more than the previous cohort. Among the 76 international events for 2025 to 2027 lined up by the HKTB, with an estimated attendance of over 180,000 MICE visitor arrivals and 27 resulted from HKCAs' efforts. The events cover diverse fields ranging from I&T to aviation and medical sciences. Some are held in Hong Kong for the first time, including IEEE Electron Devices Technology and Manufacturing Conference held in March 2025, Routes World in September 2025 and World Cancer Congress 2026. The HKTB is committed to working closely with HKCAs to welcome more world-class events to Hong Kong, attracting high-yield overnight business visitors to the city and reinforcing the city's status as the world's meeting place. Large-scale conventions facilitated by Hong Kong Convention Ambassadors: Date Events (*first-ever in Hong Kong) Theme/Sector March 2025 IEEE Electron Devices Technology and Manufacturing Conference * Innovation & Technology May 2025 IEEE International Conference on Data Engineering Innovation & Technology Jun 2025 International Society for Stem Cell Research (ISSCR) Annual Meeting* Medical sciences Sep 2025 Routes World* Aviation Dec 2025 The International Society of Sport Psychology 16 th World Congress Sports & Medical sciences 2026 Asia-Pacific Association for International Education 2026 Conference and Exhibition Education 2026 17 th Asian Congress of Oral and Maxillofacial Surgery Medical sciences 2026 Asian Venture Philanthropy Network Conference Philanthropy 2026 International Federation of Landscape Architects World Congress Architecture 2026 Lions International Convention Social Services 2026 The Association of National Olympic Committees General Assembly Sports 2026 The Council Meeting of the Asian Patent Attorneys Association Intellectual property 2026 World Cancer Congress* Medical sciences 2027 International Association for Energy Economics Annual International Conference Economics 2027 Lions Clubs International Orient and Southeast Asian Lions Forum Social Services 2027 World Organization of Family Doctors Asia Pacific Regional Conference Medical sciences Hashtag: #HKTB The issuer is solely responsible for the content of this announcement. Hong Kong Tourism Board
Malay Mail
11-06-2025
- Health
- Malay Mail
Hong Kong Hosts World's Largest ISSCR Stem Cell Gathering for the First Time
Some 2,400 stem cell and regenerative medicine pioneers convene to chart new frontiers, resulting from bidding efforts of Hong Kong Convention Ambassadors of the Hong Kong Tourism Board The University of Hong Kong, The Chinese University of Hong Kong and the Hong Kong University of Science and Technology, which are appointed organisations under the Hong Kong Convention Ambassador (HKCA) programme of the Hong Kong Tourism Board (HKTB). HONG KONG SAR - Media OutReach Newswire - 11 June 2025 - Reputed to be a leading research and development (R&D) hub for medical sciences, Hong Kong hosts the world's largest and most significant gathering of stem cell research and regenerative medicine, the International Society of Stem Cell Research (ISSCR) 2025 Annual Meeting. The event is brought to Hong Kong for the first time, thanks to the joint effort of three local universities –, which are appointed organisations under the Hong Kong Convention Ambassador (HKCA) programme of the Hong Kong Tourism Board (HKTB). The four-day meeting held on June 11-14 gathers more than 2,400 local and international experts in stem cell research and regenerative medicine from 58 countries and regions, from Asia to North America, Europe, Australia, the Middle East, and Mainland China. Pioneers share the latest advances in the field, with topics spanning the field of regenerative medicine including topics such as advances in cell therapies, fundamental discoveries, understanding disease processes and more. The four-day meeting held on June 11-14 gathers more than 2,400 local and international experts in stem cell research and regenerative medicine from 58 countries and regions, from Asia to North America, Europe, Australia, the Middle East, and Mainland China. Pioneers share the latest advances in the field, with topics spanning the field of regenerative medicine including topics such as advances in cell therapies, fundamental discoveries, understanding disease processes and more. Dr Peter Lam, HKTB Chairman, said, "The International Society for Stem Cell Research (ISSCR) is a globally leading organisation in medical sciences and research, and its annual meeting is one of the world's most significant international academic conventions in medical science. Hong Kong is the first city chosen to host this annual event in Asia after a 13-year hiatus, underscoring the city's status as the 'World's Meeting Place'. I am grateful for the active participation of the Hong Kong Convention Ambassadors from the three local universities, who leveraged their influence and network during the bidding for the host of the event to make the event come true. We are also delighted to see that more professionals from a wider range of expertise are joining HKTB's league of Convention Ambassadors, and we believe their participation can help identify and contribute to the staging of more significant international events in Hong Kong." Valentina Greco, ISSCR President, remarked, "Hosting ISSCR 2025 in Hong Kong marks a defining moment for global stem cell science. As a vibrant research hub at the crossroads of Asia and the world, Hong Kong offers an ideal setting to connect diverse scientific communities, spark new collaborations, and accelerate innovation. The ISSCR is deeply grateful to the city of Hong Kong and to our generous co-sponsors – the University of Hong Kong, The Chinese University of Hong Kong, and the Hong Kong University of Science and Technology – for their support and commitment to bringing The Global Stem Cell Event to this beautiful city. With the unwavering support of the Hong Kong Tourism Board, these three leading universities, and inspired leadership from our 2025 Annual Meeting Program Committee, this meeting exemplifies the power of partnership and shared vision. We are proud to return to Asia for the first time in more than a decade at a time when our collective progress in stem cell research and regenerative medicine and to advancing therapies that have life altering impact on patients depends on the exchange of bold ideas across borders." The extensive programme features plenary sessions, concurrent tracks, poster presentations, and networking opportunities. Contributing to the success of the event, the HKTB has provided comprehensive support, from arranging reconnaissance to venue sourcing, bid proposal, network support and more. Hong Kong Convention Ambassador Programme Aligns a Record Lineup of 180 Industry Leaders HKTB hosted the "Hong Kong Conference Ambassador Appreciation Night" last year to honor the contributions of the ambassadors in reinforcing Hong Kong as a 'World Meeting Place' Hong Kong Convention Ambassadors from the Mainland recently participated in a business forum. HKCAs have been instrumental in winning the ISSCR 2025 Annual Meeting for Hong Kong. Launched in 2020 by the HKTB as a strategic initiative, the HKCA programme recruits high-level representatives of Hong Kong's eight universities, chambers of commerce, professional organisations, public bodies, industrial entities and professional societies to act as ambassadors for Hong Kong's convention sector. With their professional influence and networks, HKCAs have led efforts to bring in events ranging from medical sciences to innovation and technology (I&T), financial services, aviation, transportation and more. The close collaboration between HKCAs and the HKTB has proven effective in promoting Hong Kong as a premier hub for world-class conventions. HKCAs have been instrumental in winning the ISSCR 2025 Annual Meeting for Hong Kong. Launched in 2020 by the HKTB as a strategic initiative, the HKCA programme recruits high-level representatives of Hong Kong's eight universities, chambers of commerce, professional organisations, public bodies, industrial entities and professional societies to act as ambassadors for Hong Kong's convention sector. With their professional influence and networks, HKCAs have led efforts to bring in events ranging from medical sciences to innovation and technology (I&T), financial services, aviation, transportation and more. The close collaboration between HKCAs and the HKTB has proven effective in promoting Hong Kong as a premier hub for world-class conventions. As an alliance of distinguished local and Mainland leaders in business, medicine, professional services, I&T and other fields, the HKCA programme has been growing from strength to strength, with 72 new members in the latest record-sized cohort for the 2025-2026 term, taking the total to about 180, some 30% more than the previous cohort. Among the 76 international events for 2025 to 2027 lined up by the HKTB, with an estimated attendance of over 180,000 MICE visitor arrivals and 27 resulted from HKCAs' efforts. The events cover diverse fields ranging from I&T to aviation and medical sciences. Some are held in Hong Kong for the first time, including IEEE Electron Devices Technology and Manufacturing Conference held in March 2025, Routes World in September 2025 and World Cancer Congress 2026. The HKTB is committed to working closely with HKCAs to welcome more world-class events to Hong Kong, attracting high-yield overnight business visitors to the city and reinforcing the city's status as the world's meeting place. Large-scale conventions facilitated by Hong Kong Convention Ambassadors: Date Events (*first-ever in Hong Kong) Theme/Sector March 2025 IEEE Electron Devices Technology and Manufacturing Conference * Innovation & Technology May 2025 IEEE International Conference on Data Engineering Innovation & Technology Jun 2025 International Society for Stem Cell Research (ISSCR) Annual Meeting* Medical sciences Sep 2025 Routes World* Aviation Dec 2025 The International Society of Sport Psychology 16th World Congress Sports & Medical sciences 2026 Asia-Pacific Association for International Education 2026 Conference and Exhibition Education 2026 17th Asian Congress of Oral and Maxillofacial Surgery Medical sciences 2026 Asian Venture Philanthropy Network Conference Philanthropy 2026 International Federation of Landscape Architects World Congress Architecture 2026 Lions International Convention Social Services 2026 The Association of National Olympic Committees General Assembly Sports 2026 The Council Meeting of the Asian Patent Attorneys Association Intellectual property 2026 World Cancer Congress* Medical sciences 2027 International Association for Energy Economics Annual International Conference Economics 2027 Lions Clubs International Orient and Southeast Asian Lions Forum Social Services 2027 World Organization of Family Doctors Asia Pacific Regional Conference Medical sciences Hashtag: #HKTB The issuer is solely responsible for the content of this announcement.
Globe and Mail
09-06-2025
- Business
- Globe and Mail
BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025
– ISSCR 2025 is the premier global event for stem cell research, drawing nearly 4,000 leaders from academia, biotech, and pharma – – BioRestorative to release new clinical data to the public prior to market open on June 13th – MELVILLE, N.Y., June 09, 2025 — BioRestorative Therapies, Inc. ('BioRestorative,' 'BRTX' or the 'Company') (NASDAQ:BRTX), a clinical-stage regenerative medicine company developing stem cell-based therapies for serious musculoskeletal conditions, today announced that new preliminary, blinded clinical data from 30 patients enrolled in its ongoing Phase 2 trial of BRTX-100 for the treatment of chronic lumbar disc disease (cLDD) will be presented at the prestigious International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting, held June 11–14, 2025, in Hong Kong. The highly anticipated presentation will be delivered by Francisco Silva, Vice President of Research and Development at BioRestorative, on Friday, June 13, at 5:00 p.m. HKT, as part of ISSCR 2025's clinical innovations track. The Company will issue a press release pre-market that day, detailing the newly reported data. 'This represents a milestone moment for BioRestorative,' said Lance Alstodt, Chief Executive Officer. 'With preliminary data from twice as many patients as previously shared, we are seeing strong, consistent signals around both safety and functional improvement. We are eager to bring this update to the global scientific community at the world's most influential stem cell conference.' BRTX-100 is BioRestorative's lead clinical candidate — a hypoxic-cultured, autologous mesenchymal stem cell therapy designed to target areas of the body with limited blood flow, such as damaged spinal discs. The ongoing Phase 2 study is a prospective, randomized, double-blinded, placebo-controlled trial evaluating BRTX-100 in patients with cLDD across up to 16 U.S. clinical sites. A total of 99 patients will be enrolled, randomized 2:1 to receive either BRTX-100 or placebo via a single intradiscal injection. The presentation, titled 'Stem Cell Therapy for Chronic Lumbar Disc Disease: Phase 2 Clinical Safety and Feasibility Data of Intradiscal Injections of Hypoxic Cultured Mesenchymal Stem Cells,' will highlight key preliminary outcomes focused on patient-reported pain and function metrics, as well as safety endpoints. About the ISSCR 2025 Annual Meeting ISSCR 2025 is the largest and most influential gathering of stem cell scientists and regenerative medicine experts globally, attracting nearly 4,000 participants from over 80 countries. It serves as a key venue for groundbreaking clinical and translational research, offering BioRestorative a high-profile platform to share its latest advancements. For more information on ISSCR 2025, visit About BioRestorative Therapies, Inc. BioRestorative (NASDAQ:BRTX) is a clinical-stage biotechnology company developing cell-based therapies using adult stem cells to address unmet needs in musculoskeletal and metabolic diseases. The Company's pipeline includes BRTX-100, a novel therapy targeting chronic lumbar disc disease, and ThermoStem ®, a platform focused on brown adipose (fat) biology for the treatment of obesity and metabolic disorders. The Company also operates a commercial BioCosmeceutical platform. For more information, please visit Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including, without limitation, those set forth in the Company's latest Form 10-K, filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements. Contact: Stephen Kilmer Investor Relations Direct: (646) 274-3580 Email: skilmer@ Featured Image @ Freepik Read more investing news on to the PressReach RSS feeds:
RNZ News
21-05-2025
- Science
- RNZ News
Axolotls lending a hand to human limb regeneration
Photo: Whited Labs Photo: Whited Labs While millions of people are living with the consequences of limb amputation due to injury or disease, axolotl salamanders can replace entire lost limbs, which are anatomically similar to human limbs. Jessica Whited is an Assistant Professor of Stem Cell and Regenerative Biology at Harvard University. Here at the Whited Lab she studies limb regeneration in axolotl salamanders, with the ultimate goal of discovering how to regenerate limbs in humans. Whited has developed several molecular tools to manipulate gene expression during limb regeneration, and is exploring signaling events in wound healing that initiate the regenerative process. Jessica speaks with Mihi Forbes. Photo: Whited Labs
